Overview

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive to BCG Therapy

Status:
NOT_YET_RECRUITING
Trial end date:
2030-06-15
Target enrollment:
Participant gender:
Summary
interventional study of intravesical chemotherapy and sistemic immunotherapy in NMIBC
Phase:
PHASE2
Details
Lead Sponsor:
BLATAM
Treatments:
Gemcitabine